Glaucoma: Validated and Facile In Vivo Experimental Models of a Chronic Neurodegenerative Disease for Drug Development

E-ISSN： 1875-6158|5|1|43-49

ISSN： 1568-0150

Source： Current Medicinal Chemistry - Central Nervous System Agents, Vol.5, Iss.1, 2005-03, pp. : 43-49

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In Vivo Experimental Models of Epilepsy

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 10, Iss. 4, 2010-12 ,pp. : 298-309

Bentham Science Publishers

Access to resources Recommend Favorite

The emerging utility of animal models of chronic neurodegenerative diseases

By Kahle P.J. Haass C.

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 1, 2001-02 ,pp. : 125-132

Informa Healthcare

Access to resources Recommend Favorite

Implications of Parkinson's Disease Pathophysiology for the Development of Cell Replacement Strategies and Drug Discovery in Neurodegenerative Diseases

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 7, 2012-11 ,pp. : 907-920

Bentham Science Publishers

Access to resources Recommend Favorite

Experimental Mouse Models of Thrombosis Optimized for Drug Discovery and Development

Letters in Drug Design & Discovery, Vol. 2, Iss. 5, 2005-08 ,pp. : 403-411

Bentham Science Publishers

Access to resources Recommend Favorite

Chronic obstructive pulmonary disease: new opportunities for drug development

By Barnes P.J.

Trends in Pharmacological Sciences, Vol. 19, Iss. 10, 1998-10 ,pp. : 415-423

Elsevier

Access to resources Recommend Favorite